ENDURANT CAPITAL MANAGEMENT LP – Bristol-Myers Squibb Company Transaction History
ENDURANT CAPITAL MANAGEMENT LP portfolio value:
$11.28M
portfolio value
Bristol-Myers Squibb Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | 0.00% | 158.72K shares | 11.28M | $71.09 | 158.72K |
| Q2 2022 | share | Decrease | -100.00% | -194.68K shares | -14.21M | $77 | 0 |
| Q1 2022 | share | Increase | 0.00% | 194.68K shares | 14.21M | $73.03 | 194.68K |
| Q4 2021 | share | Decrease | -100.00% | -211.82K shares | -12.53M | $62.52 | 0 |
| Q3 2021 | share | Increase | +109.56% | 110.74K shares | 5.77M | $59.17 | 211.82K |
| Q2 2021 | share | Decrease | -56.78% | -132.81K shares | -8.01M | $65.79 | 101.08K |
| Q1 2021 | share | Decrease | -4.17% | -10.16K shares | -373K | $62.15 | 233.89K |
| Q4 2020 | share | Decrease | -37.44% | -146.09K shares | -8.38M | $60.6 | 244.06K |
| Q3 2020 | share | Increase | +980.50% | 354.04K shares | 21.4M | $58 | 390.15K |
| Q2 2020 | share | Decrease | -73.63% | -100.81K shares | -5.50M | $56.14 | 36.10K |
| Q1 2020 | share | Decrease | -65.89% | -264.50K shares | -18.13M | $52.79 | 136.92K |
| Q4 2019 | share | Increase | +37.51% | 109.50K shares | 10.96M | $60.36 | 401.43K |
| Q3 2019 | share | Increase | +238.28% | 205.62K shares | 10.89M | $47.3 | 291.92K |
| Q2 2019 | share | Decrease | -70.37% | -204.98K shares | -9.98M | $41.93 | 86.29K |
| Q1 2019 | share | Increase | +490.39% | 241.94K shares | 11.33M | $43.73 | 291.28K |
| Q4 2018 | share | Decrease | -36.72% | -28.63K shares | -2.27M | $47.21 | 49.33K |
| Q3 2018 | share | Increase | 0.00% | 77.97K shares | 4.84M | $56.02 | 77.97K |